<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    AVROBIO, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About AVROBIO, Inc.

    AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical stage company developing disruptive therapies that have the potential to transform patients’ lives in a single dose. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $440,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Geoff MacKay
    • FOUNDED
      2015
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Mylan N.V.

    Mylan N.V.

    Mylan is a global pharmaceutical company committed to setting new standards in hea...

    Mylan is a global pharmaceutical company commit...

    Filing Type:    PU
    Stemline Therapeutics, Inc.

    Stemline Therapeutics, Inc.

    Stemline Therapeutics, Inc. is a commercial-stage biopharmaceutical company focuse...

    Stemline Therapeutics, Inc. is a commercial-sta...

    Filing Type:    PU
    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    MeiraGTx Holdings plc

    MeiraGTx Holdings plc

    We are a vertically integrated, clinical stage gene therapy company with four ongo...

    We are a vertically integrated, clinical stage ...

    Filing Type:    PU
    NeoGenomics, Inc.

    NeoGenomics, Inc.

    NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory and phar...

    NeoGenomics, Inc. is a high-complexity CLIA-cer...

    Filing Type:    PU
    Exelixis, Inc.

    Exelixis, Inc.

    Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncol...

    Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) ...

    Filing Type:    PU
    Voyager Therapeutics, Inc.

    Voyager Therapeutics, Inc.

    Voyager Therapeutics is developing life-changing gene therapies for fatal and debi...

    Voyager Therapeutics is developing life-changin...

    Filing Type:    PU
    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into ...

    Sangamo Therapeutics, Inc. is focused on transl...

    Filing Type:    PU
    Audentes Therapeutics, Inc.

    Audentes Therapeutics, Inc.

    Audentes Therapeutics is a leading AAV-based genetic medicines company focused on ...

    Audentes Therapeutics is a leading AAV-based ge...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.